Vaginal misoprostol versus intravenous oxytocin for the management of second-trimester pregnancies with intrauterine fetal death: A randomized clinical trial.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The aim of this study was to compare vaginal misoprostol versus intravenous (i.v.) oxytocin in the management of pregnancies with second-trimester intrauterine fetal death (IUFD).

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J. Obstet. Gynaecol. Res.

Title: The journal of obstetrics and gynaecology research

Publisher: Wiley-Blackwell

ISSN (Electronic): 1447-0756

ISSN (Print): 1341-8076

Publication date (Electronic): Mar 2016

Volume: 42

Issue: 3

Affiliations

[1 ] Maternal, Fetal and Neonatal Research Center, Tehran University of Medical Sciences, Tehran, Iran.

[2 ] Shariati Hospital, Hormozgan University of Medical Sciences, Bandar-Abbas, Iran.

[3 ] Shohadaye Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Article

DOI: 10.1111/jog.12910

PubMed ID: 26663590

SO-VID: 80af6790-33e2-423f-8d94-6a34d0b8630b

History

Keywords: fetus,induction,intrauterine fetal death,labor,demise

Data availability:

Keywords: fetus, induction, intrauterine fetal death, labor, demise

Comments

Comment on this article

scite_

Cited by 4

See all cited by